Literature DB >> 9333341

Use of two-stage test statistic in the two-period crossover trials.

S J Wang1, H M Hung.   

Abstract

For two-period crossover trials where the residual carryover can only exist in the presence of treatment effect, Willan (1988, Biometrics 44, 211-218) recommended use of the maximum test statistic that chooses the analysis with the larger test statistic corresponding to the parallel analysis and the crossover analysis. We construct two alternative two-stage test procedures, based on Grizzle's approach, that maintain the actual type I error rate at the desirable level. The power, accuracy, and precision of the analysis based on the modified two-stage procedures are compared to those based on the parallel analysis, crossover analysis, and the maximum test statistic.

Entities:  

Mesh:

Year:  1997        PMID: 9333341

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  4 in total

1.  Assessing the effectiveness of topical betamethasone to treat chronic chilblains: a randomised clinical trial in primary care.

Authors:  Ibo H Souwer; Jacobus Hj Bor; Paul Smits; Antoine Lm Lagro-Janssen
Journal:  Br J Gen Pract       Date:  2017-02-13       Impact factor: 5.386

2.  Nifedipine vs Placebo for Treatment of Chronic Chilblains: A Randomized Controlled Trial.

Authors:  Ibo H Souwer; Jacobus H J Bor; Paul Smits; Antoine L M Lagro-Janssen
Journal:  Ann Fam Med       Date:  2016-09       Impact factor: 5.166

3.  Plasticity, permanence, and patient performance: study design and data analysis in the cognitive rehabilitation of acquired communication impairments.

Authors:  Patricia E Cowell; Sandra P Whiteside; Fay Windsor; Rosemary A Varley
Journal:  Front Hum Neurosci       Date:  2010-11-26       Impact factor: 3.169

4.  Comparison of chronic kidney disease trial designs and analysis strategies.

Authors:  John Lawrence
Journal:  Kidney Res Clin Pract       Date:  2021-03-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.